TER.CN - TerrAscend Corp.

Canadian Sec - Canadian Sec Delayed Price. Currency in CAD
4.2700
+0.0600 (+1.43%)
At close: 3:59PM EDT
Stock chart is not supported by your current browser
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
  • Short Term
    2W - 6W
  • Mid Term
    6W - 9M
  • Long Term
    9M+
Previous Close4.2100
Open4.2100
Bid4.2000 x 0
Ask4.2700 x 0
Day's Range4.1000 - 4.2800
52 Week Range1.7400 - 7.1000
Volume52,852
Avg. Volume75,006
Market Cap313.857M
Beta (5Y Monthly)0.82
PE Ratio (TTM)N/A
EPS (TTM)-1.8690
Earnings DateMay 28, 2020
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • CNW Group

    TerrAscend to Host 2020 Investor Day

    Senior Leadership Team to Share Details on Company Performance and StrategyCanopy Growth's David Klein and TerrAscend's Chairman Jason Wild to Participate in Moderated Fireside Chat to Discuss U. Market OpportunitiesNEW YORK and TORONTO, July 17, 2020 /CNW/ - TerrAscend Corp.

  • CNW Group

    TerrAscend Announces Date of 2020 Annual General Meeting and Update on Filings

    As a result of the ongoing impact of the COVID-19 pandemic and in accordance with continued public health measures, the Company will host its AGM in a virtual-only format. In addition, the Company announced that it will rely on the temporary blanket relief provided by Canadian Securities Administrators, including the exemptive relief contained in Ontario Instrument 51-504 Temporary Exemptions from Certain Requirements to File or Send Securityholder Materials of the Ontario Securities Commission, to postpone the public filing of its executive compensation disclosure required under National Instrument 51-102 Continuous Disclosure Obligations until such time as the disclosure is filed and delivered to shareholders as part of the Company's information circular relating to its AGM. The Canadian Securities Exchange ("CSE") has neither approved nor disapproved the contents of this news release.

  • CNW Group

    TerrAscend Announces the Opening of Third Apothecarium Dispensary in Pennsylvania

    NEW YORK and TORONTO , June 30, 2020 /CNW/ - TerrAscend Corp. ("TerrAscend") (TER.CN) (TRSSF), a leading North American cannabis operator, today announced that it will officially open its third retail dispensary location in Pennsylvania on July 6, 2020 . The newly renovated, 5,000 square foot Apothecarium medical dispensary is located at 2701 Lincoln Hwy East, Thorndale, PA.

  • Canadian Securities Exchange Highlights Five Key Takeaways From Its 2020 "Cannabis Month" Podcast and Video Series
    Newsfile

    Canadian Securities Exchange Highlights Five Key Takeaways From Its 2020 "Cannabis Month" Podcast and Video Series

    Toronto, Ontario--(Newsfile Corp. - June 9, 2020) - The Canadian Securities Exchange ("CSE" or "the Exchange") is pleased to announce that it recently completed Cannabis Month, an informative series of podcast interviews with senior executives and other thought leaders across the cannabis sector. The interviews and related content were provided through the CSE's website, YouTube (CSE TV) and Instagram (@CanadianExchange) feeds.The podcast guests included cannabis industry pioneers and entrepreneurs including Bruce Linton (founder of ...

  • CNW Group

    TerrAscend Provides Update and Closing Details for its Oversubscribed US$37 Million Non-Brokered Private Placement

    NEW YORK and TORONTO , May 29, 2020 /CNW/ - TerrAscend Corp. ("TerrAscend" or the "Company") (CSE:TER, OTCQX: TRSSF), a leading North American cannabis operator, today provided an update regarding its previously announced US$30.0 million non-brokered private placement (the "Offering"). As a result of strong investor demand, the Company has upsized the offering to approximately US$37.0 million , which was oversubscribed and has been fully allocated. TerrAscend closed the second tranche of the Offering on May 28, 2020 , issuing 3,561 Units at an issue price of US$2,000 per Unit resulting in proceeds to the Company of US$7.1 million .

  • CNW Group

    TerrAscend Reports First Quarter Net Sales of $34.8 Million and Adjusted EBITDA of $4.9 Million

    TerrAscend Reports First Quarter Net Sales of $34.8 Million and Adjusted EBITDA of $4.9 Million

  • CNW Group

    TerrAscend Closes Initial Tranche of US$30 Million Non-Brokered Private Placement

    NEW YORK and TORONTO , May 25, 2020 /CNW/ - TerrAscend Corp. ("TerrAscend" or the "Company") (CSE:TER, OTCQX: TRSSF), a leading North American cannabis operator, today announced the closing of the first tranche of its previously announced non-brokered private placement ("the Offering"), issuing 13,646 Units at an issue price of US$2,000 per Unit resulting in proceeds to the Company of US$27.3 million . Each noninterest-bearing Unit is comprised of one convertible preferred share in the capital of the Company (each, a "Convertible Preferred Share") and one convertible preferred share purchase warrant (each, a "Warrant").

  • CNW Group

    TerrAscend To Host First Quarter 2020 Investor Conference Call

    TerrAscend To Host First Quarter 2020 Investor Conference Call

  • CNW Group

    TerrAscend Announces US$30 Million Non-Brokered Private Placement with Indicative Lead Orders of Approximately US$28 Million

    The Company has received initial investor commitments totaling US$28.0 million , including a US$20.0 million lead order from JW Asset Management LLC ("JW Asset Management") which is expected to close on or about May 21, 2020 , subject to customary closing conditions. The Company intends to use the proceeds from the Offering to fund TerrAscend's growth initiatives including its U.S. expansion strategy, capital expenditures, working capital, and general corporate purposes. The Offering consists of a number of units of the Company (each, a "Unit") issued at the price of $2,000 per Unit (the "Purchase Price").

  • CNW Group

    TerrAscend to Present at Canaccord Genuity's Global Cannabis Conference

    NEW YORK and TORONTO , May 6, 2020 /CNW/ - TerrAscend Corp. ("TerrAscend" or the "Company") (CSE: TER, OTCQX: TRSSF), a leading North American cannabis operator, today announced that Jason Ackerman , CEO and Executive Chairman, will be presenting at Canaccord Genuity's 4th Annual Global Cannabis Conference. In addition to the webcast presentation, Mr. Ackerman, Jason Wild , Chairman, and Keith Stauffer , Chief Financial Officer, will be conducting virtual one-on-one meetings with investors throughout the afternoon. The Canadian Securities Exchange ("CSE") has neither approved nor disapproved the contents of this news release.

  • TerrAscend Strengthens Partnership with Precision Extraction Solutions
    CNW Group

    TerrAscend Strengthens Partnership with Precision Extraction Solutions

    NEW YORK and TORONTO , May 5, 2020 /CNW/ - TerrAscend Corp. (CSE: TER; OTCQX: TRSSF) ("TerrAscend" or the "Company"), a leading North American cannabis operator, today announced an expanded partnership with Precision Extraction Solutions ("Precision"). Through a newly signed agreement, Precision, a Detroit -based company with an extensive portfolio of cannabis extraction, refinement, and processing technologies, will provide state-of-the-art equipment for TerrAscend's current and future product lines. Precision is designing a multi-solvent lab in TerrAscend's New Jersey facility, currently under construction in Boonton Township .

  • CNW Group

    TerrAscend Announces Appointment of Keith Stauffer as Chief Financial Officer

    TORONTO , April 24, 2020 /CNW/ - TerrAscend Corp. ("TerrAscend" or the "Company") (CSE: TER, OTCQX: TRSSF), a leading North American cannabis operator, today announced the appointment of Keith Stauffer as Chief Financial Officer ("CFO"). Mr. Stauffer will be based in New York City and is expected to commence his role as CFO on April 27, 2020 , subject to CSE approval. Mr. Stauffer has over 25 years of experience as a business executive holding various senior finance and leadership roles across multiple industries.

  • CNW Group

    TerrAscend Announces Fourth Quarter and Full Year 2019 Financial Results

    TerrAscend Announces Fourth Quarter and Full Year 2019 Financial Results

  • TerrAscend Announces Management Changes
    CNW Group

    TerrAscend Announces Management Changes

    TORONTO , April 14, 2020 /CNW/ - TerrAscend Corp. (CSE: TER; OTCQX: TRSSF) ("TerrAscend" or "the Company"), a leading North American cannabis operator, announced today that it has appointed Jason Ackerman as Chief Executive Officer ("CEO"). The Company will also relocate its financial operations to its U.S. headquarters in New York City .

  • TerrAscend to Host Fourth Quarter 2019 Investor Conference Call
    CNW Group

    TerrAscend to Host Fourth Quarter 2019 Investor Conference Call

    TerrAscend to Host Fourth Quarter 2019 Investor Conference Call

  • TerrAscend's Award-Winning Apothecarium to Debut Its First Two Pennsylvania Dispensaries
    CNW Group

    TerrAscend's Award-Winning Apothecarium to Debut Its First Two Pennsylvania Dispensaries

    TORONTO , March 30, 2020 /CNW/ - TerrAscend Corp. (CSE: TER; OTCQX: TRSSF) ("TerrAscend" or the "Company") a leading North American cannabis operator, today announced it will open its award-winning Apothecarium ("The Apothecarium") branded dispensaries in two Pennsylvania locations; one in Lancaster and a second in Plymouth Meeting . Both locations will serve Pennsylvania medical marijuana patients.

  • TerrAscend Provides Business Update on Response to COVID-19
    CNW Group

    TerrAscend Provides Business Update on Response to COVID-19

    TORONTO , March 27, 2020 /CNW/ - TerrAscend Corp. (CSE: TER; OTCQX: TRSSF) ("TerrAscend" or the "Company"), a leading North American Cannabis operator, today provided an update on the current state of its business amid the COVID-19 pandemic. Over the last two weeks, cannabis operations have been deemed essential in the jurisdictions in which TerrAscend is licensed, allowing the Company to remain fully operational and continue to serve customers and patients. To help service increased demand, the Company is hiring additional employees at its retail, cultivation, and processing facilities.

  • When the Smoke Clears, Canopy Growth Stock Will Be a Winner
    InvestorPlace

    When the Smoke Clears, Canopy Growth Stock Will Be a Winner

    The selloff in the market and in Canopy Growth (NYSE:CGC) stock both continue. Markets plunged again earlier this week, and Canopy stock hasn't been immune to the selling pressure. Now, shares trade back where they did in 2017.Source: Jarretera / Shutterstock.com As I've argued over the past few weeks, investors need to keep their cool. This selloff has not been easy and certainly has not been fun. But over time, the economy and the markets will recover.In the meantime, however, the volatility is dispiriting. However, as I've told subscribers of my Cannabis Cash Weekly service, in these environments investors sometimes have to step back and let the chaos play out.InvestorPlace - Stock Market News, Stock Advice & Trading TipsTaking that step back, the opportunity in CGC stock becomes more clear. The long-term growth opportunity in cannabis is delayed -- not eliminated. Canopy is the industry's leader, and should remain so. In fact, it may emerge with an even stronger position. * 10 Stocks to Invest In for a Post-Coronavirus Whipsaw Canopy isn't going anywhere. This, too, shall pass -- and when it does, CGC stock will rally sharply. Canopy Cuts BackEven before panic gripped the markets, it was becoming increasingly clear that the cannabis industry was headed for a shakeout. And that shakeout is almost guaranteed at this point.In the sector as a whole, there is too much debt and too much capacity. Canopy chief executive officer David Klein made precisely that point in an interview on Feb. 14. "There's not a lot of market demand for cannabis production facilities," he told Yahoo! Finance. "There's a lot of capacity in Canada and no logical buyers."That capacity is why Canopy announced earlier this month that it was closing two facilities in British Columbia. Furthermore, a greenhouse project in Ontario also is being canceled. Canopy isn't throwing good money after bad.Wall Street largely cheered the move -- for good reason. It cuts Canopy's costs, and in turn, speeds its path toward profitability. It also keeps the company from participating in "race to the bottom" pricing in wholesale cannabis.It's also a decision many other cannabis companies won't be able to make. An Industry Shakeout LoomsCanopy can make that decision because of its fortress balance sheet. In 2018, Constellation Brands (NYSE:STZ,NYSE:STZ.B) invested some $4 billion into Canopy Growth.Much of that money has been spent. Canopy has made acquisitions, and spent heavily to build out production assets. In fact, it's clear in retrospect that previous management spent too much. That's a key reason why Constellation sent Klein -- formerly its chief financial officer -- to take the top spot at Canopy.However, Canopy still has a good chunk of that cash remaining. As of Dec. 31, the company had 2.3 billion CAD (about $1.6 billion) in cash on its balance sheet. With losses coming down and long-term debt of just 536 million CAD ($373 million), the company is in excellent financial shape.To put it simply, Canopy isn't going bankrupt -- but other producers will. There's a real chance the equity in Aurora Cannabis (NYSE:ACB) gets wiped out, one reason I've long recommended even cannabis bulls avoid that name. Moreover, MedMen Enterprises (OTCMKTS:MMNFF) had to call off its acquisition of PharmaCann -- likely due to financing worries. Its OTC stock price -- just 19 cents -- shows its desperate state.The news is just as bad, if not worse, for many smaller, private operators. Those companies don't have the cash to weather store closures or any short-term effects.Canopy, however, does. And that positions it well going forward. How CGC Stock Can BenefitCertainly, a worldwide pandemic is not how anyone hoped the cannabis industry would become more rational. But it's also likely that the response to the coronavirus from China simply will be the catalyst, not the cause. Given debt levels and overcapacity, many smaller operators were going to fail regardless.That said, Canopy would benefit either way. In fact, a recent transaction shows how. Last week, Canopy and TerrAscend (OTCMKTS:TRSSF) entered into a loan agreement. Canopy is lending TerrAscend 80.5 million CAD, backed by TerrAscend's assets.The loan has an interest rate of 6.1% annually over the next decade -- but that's not the prize. Canopy also received more than 17 million warrants to buy TerrAscend shares, most of them at an exercise price of 3.74 CAD per share.If TerrAscend, which currently trades below 2 CAD, posts a huge rally, Canopy will get its money back while also owning a nice chunk of the company at an attractive price.If it doesn't, though, Canopy has first claim on its assets, brands, and retail operations.This kind of savvy deal is what Klein was hired to make. And it highlights the opportunities Canopy will have for the next few years. The company can patiently wait out the upheaval in its industry, and pick its spots to make investments that can drive significant value.Of course, that's exactly what investors should be doing right now. As they do so, they should give at least a long look to Canopy Growth stock.Matthew McCall left Wall Street to actually help investors -- by getting them into the world's biggest, most revolutionary trends BEFORE anyone else. The power of being "first" gave Matt's readers the chance to bank +2,438% in Stamps.com (STMP), +1,523% in Ulta Beauty (ULTA) and +1,044% in Tesla (TSLA), just to name a few. Click here to see what Matt has up his sleeve now. Matt does not directly own the aforementioned securities. More From InvestorPlace * America's Richest ZIP Code Holds Wealth Gap Secret * 10 of the Best Long-Term Stocks to Buy in a Bear Market * 7 "Perfect 10" Healthcare Stocks to Buy Now * Where the FANG Stocks Sit in This Wild Market The post When the Smoke Clears, Canopy Growth Stock Will Be a Winner appeared first on InvestorPlace.

  • TerrAscend Canada Announces C$80.5 Million Financing Arrangement With Canopy Growth Corporation
    CNW Group

    TerrAscend Canada Announces C$80.5 Million Financing Arrangement With Canopy Growth Corporation

    TORONTO , March 11, 2020 /CNW/ - TerrAscend Corp. ("TerrAscend") (CSE:TER, OTCQX: TRSSF), today announced that  TerrAscend Canada Inc. ("TerrAscend Canada"), its wholly owned subsidiary, has entered into a loan financing arrangement  with Canopy Growth Corporation ("Canopy Growth" ) (TSX:WEED, NYSE:CGC) in the amount of C$80.5 million (the "Loan") pursuant to a secured debenture (the "Debenture"). In connection with the funding of the Loan, TerrAscend has issued 17,808,975 common share purchase warrants to Canopy Growth (the "Warrants"). Canopy Growth initially invested in TerrAscend in November 2017 alongside funds managed by TerrAscend Chairman Jason Wild .

  • TerrAscend and Canopy Rivers Amend Terms of Loan to Comply with TSX Policies
    CNW Group

    TerrAscend and Canopy Rivers Amend Terms of Loan to Comply with TSX Policies

    TORONTO , Feb. 5, 2020 /CNW/ - TerrAscend Corp. (CSE: TER; OTCQX: TRSSF) ("TerrAscend" or the "Company"), the first global cannabis company licensed for sales in the U.S., Canada , and the EU, announced today that the terms of its previously announced US$10 million loan (the "Loan") from Canopy Rivers Corporation ("Canopy Rivers"), a wholly-owned subsidiary of Canopy Rivers Inc. (TSX: RIV, OTC: CNPOF), to TerrAscend Canada Inc. ("TerrAscend Canada"), a wholly-owned subsidiary of TerrAscend, have been amended.

  • TerrAscend Utah, LLC Awarded Processing License in Utah
    CNW Group

    TerrAscend Utah, LLC Awarded Processing License in Utah

    TORONTO , Jan. 30, 2020 /CNW/ - TerrAscend Corp. (CSE: TER; OTCQX: TRSSF) ("TerrAscend" or "the Company"), the first global cannabis company licensed for sales in the U.S., Canada , and the EU, announced today that its majority owned subsidiary, TerrAscend Utah, LLC ("TerrAscend Utah") was awarded approval for a Medical Cannabis Processor License by the Utah Department of Agriculture and Food on January 29 , 2020. TerrAscend Utah's processing facility will be located in St George , Utah. "We are pleased St. George will have a company like TerrAscend in our community," said Jeriah Threlfall , President, St George Economic Development.

  • TerrAscend Announces Leadership Changes and Appoints Jason Ackerman Interim CEO
    CNW Group

    TerrAscend Announces Leadership Changes and Appoints Jason Ackerman Interim CEO

    Jason Ackerman , Executive Chairman of the Company, has been named interim CEO, replacing Michael Nashat , who will continue to serve as a member of the Company's Board of Directors and act as a strategic advisor to the Company. The changes are effective immediately.

  • CNW Group

    TerrAscend Announces Termination of Gravitas Nevada Ltd. Acquisition

    TORONTO , Jan. 27, 2020 /CNW/ - TerrAscend Corp. (CSE: TER; OTCQX: TRSSF) ("TerrAscend" or "the Company"), the first and only global cannabis company licensed for sales in Canada , the U.S., and the EU, today announced the termination of the Securities Purchase Agreement (the "Agreement"), pursuant to which TerrAscend would have acquired all of the issued and outstanding equity interests of Gravitas Nevada Ltd. ("Gravitas"), a vertically-integrated business engaged in the cultivation, processing, packaging and dispensing of cannabis and cannabis related products in Nevada . Gravitas operates a retail cannabis dispensary in Las Vegas, Nevada under the trade name "The Apothecarium."  The transaction, for $33 .5mm in cash and 625 proportionate voting shares in the equity of TerrAscend equivalent to 625,000 common shares of the Company, was originally announced on February 11 , 2019.

  • Market Exclusive

    TerrAscend Gets Cultivation Permit in New Jersey

    TerrAscend (CSE: TER) (OTCQX: TRSSF) announced that it has received a permit to cultivate medical marijuana from the New Jersey Department of Health. The company's subsidiary TerrAscend NJ will immediately begin cultivation operations at its facility in Boonton Township, located in northern New Jersey. TerrAscend NJ is the second entity to receive its cultivation permit among […]The post TerrAscend Gets Cultivation Permit in New Jersey appeared first on Market Exclusive.

  • TerrAscend Awarded Permit to Cultivate by New Jersey Department of Health
    CNW Group

    TerrAscend Awarded Permit to Cultivate by New Jersey Department of Health

    TORONTO , Jan. 16, 2020 /CNW/ - TerrAscend Corp. (CSE: TER; OTCQX: TRSSF) ("TerrAscend" or "the Company"), the first and only global cannabis company licensed for sales in Canada , the U.S., and the EU, today announced that TerrAscend NJ, LLC ("TerrAscend NJ") has been issued a permit to cultivate medical marijuana by the New Jersey Department of Health ("NJ DOH"). Cultivation operations will commence immediately at its facility in Boonton Township , located in northern New Jersey . In December 2018 , TerrAscend was awarded the right to apply for one of six permits, out of 146 applications, for a vertically-integrated permit to cultivate, process and dispense medical cannabis in the State of New Jersey .